Most hospital boards approve AI deployments without a thorough review. This isn’t due to a lack of concern, but rather because there hasn’t been a system in place to provide visibility.

 

Here’s the reality: A health system might deploy an AI tool in radiology that performs well and is well-received. Six months later, another vendor introduces a second tool for oncology and a third for clinical documentation. Each tool is approved in isolation, with its own data access, logic, and potential failure modes.

 

By year-end, there could be eleven AI tools operating within the organisation. The CIO may be aware of seven, the CMO of four, and the CFO of just two—those with the largest invoices. Yet, no one knows which tools are genuinely enhancing patient outcomes.

 

This isn’t merely a technology issue; it’s a visibility challenge. Healthcare AI is expanding more rapidly than governance structures can adapt, and the disconnect between deployed tools and leadership understanding is increasing each quarter.

 

According to the Grant Thornton 2026 AI Impact Survey, 78% of organisations would fail an independent AI governance audit within 90 days. In healthcare, where clinical stakes are high and regulations are tightening, this statistic should raise alarms, but it often doesn’t.

 

Proactive health systems aren’t waiting for a governance crisis. They are managing AI performance with the same rigour as clinical performance – ensuring visibility, accountability, and clarity between what’s operational and what’s effective.

 

The transition from viewing AI as a collection of tools to a managed capability is crucial for scaling AI responsibly, rather than accumulating risks silently.

 

In your next leadership meeting, consider asking not ‘are we using AI?’ but ‘do we actually know what all AI is doing?’

Shailendra Gupta
(Co-Founder and CEO of Mind IT Systems)

 

Shailendra Gupta co-founded Mind IT Systems in 2014. Over eleven years the company has modernised and rebuilt software for businesses across fintech, healthcare, supply chain, and business services — in India, the UAE, New Zealand, the UK, and the US. The decision between modernising and rebuilding comes up in almost every legacy engagement we handle, and the right answer is rarely obvious at the outset.